These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 34817226)

  • 1. Comparison of the Performance of the PanBio COVID-19 Antigen Test in SARS-CoV-2 B.1.1.7 (Alpha) Variants versus non-B.1.1.7 Variants.
    van Ogtrop ML; van de Laar TJW; Eggink D; Vanhommerig JW; van der Reijden WA
    Microbiol Spectr; 2021 Dec; 9(3):e0088421. PubMed ID: 34817226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of CerTest and Panbio antigen rapid diagnostic tests to diagnose SARS-CoV-2 infection.
    Pérez-García F; Romanyk J; Gómez-Herruz P; Arroyo T; Pérez-Tanoira R; Linares M; Pérez Ranz I; Labrador Ballestero A; Moya Gutiérrez H; Ruiz-Álvarez MJ; Cuadros-González J
    J Clin Virol; 2021 Apr; 137():104781. PubMed ID: 33639492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 rapid antigen test sensitivity and viral load in newly symptomatic hospital employees in Berlin, Germany, December, 2020 to February, 2022: an observational study.
    Meiners L; Horn J; Jones TC; Mühlemann B; Schmidt ML; Walper F; Menzel P; Schwarzer R; Rose R; Krumbholz A; Corman VM; Seybold J; Drosten C
    Lancet Microbe; 2024 Jun; 5(6):e538-e546. PubMed ID: 38759669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern.
    Osterman A; Iglhaut M; Lehner A; Späth P; Stern M; Autenrieth H; Muenchhoff M; Graf A; Krebs S; Blum H; Baiker A; Grzimek-Koschewa N; Protzer U; Kaderali L; Baldauf HM; Keppler OT
    Med Microbiol Immunol; 2021 Dec; 210(5-6):263-275. PubMed ID: 34415422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests.
    Rodgers MA; Olivo A; Harris BJ; Lark C; Luo X; Berg MG; Meyer TV; Mohaimani A; Orf GS; Goldstein Y; Fox AS; Hirschhorn J; Glen WB; Nolte F; Landay A; Jennings C; Moy J; Servellita V; Chiu C; Batra R; Snell LB; Nebbia G; Douthwaite S; Tanuri A; Singh L; de Oliveira T; Ahouidi A; Mboup S; Cloherty GA
    J Clin Virol; 2022 Feb; 147():105080. PubMed ID: 35086043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of False-Positive SARS-CoV-2 Antigen Results with Testing Conditions outside Manufacturer Recommendations: A Scientific Approach to Pandemic Misinformation.
    Patriquin G; Davidson RJ; Hatchette TF; Head BM; Mejia E; Becker MG; Meyers A; Sandstrom P; Hatchette J; Block A; Smith N; Ross J; LeBlanc JJ
    Microbiol Spectr; 2021 Oct; 9(2):e0068321. PubMed ID: 34668722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of a SARS-CoV-2 rapid antigen test in a large, Norwegian cohort.
    Landaas ET; Storm ML; Tollånes MC; Barlinn R; Kran AB; Bragstad K; Christensen A; Andreassen T
    J Clin Virol; 2021 Apr; 137():104789. PubMed ID: 33736946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of Panbio and SD Biosensor antigen rapid diagnostic tests for COVID-19 diagnosis.
    Pérez-García F; Romanyk J; Moya Gutiérrez H; Labrador Ballestero A; Pérez Ranz I; González Arroyo J; González Ventosa V; Pérez-Tanoira R; Domingo Cruz C; Cuadros-González J
    J Med Virol; 2021 Sep; 93(9):5650-5654. PubMed ID: 34002864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased Sensitivity of Rapid Antigen Test Is Associated with a Lower Viral Load of Omicron than Delta SARS-CoV-2 Variant.
    Cocherie T; Bastide M; Sakhi S; Zafilaza K; Flandre P; Leducq V; Jary A; Burrel S; Louet M; Calvez V; Marcelin AG; Marot S
    Microbiol Spectr; 2022 Oct; 10(5):e0192222. PubMed ID: 36125269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Evaluation of the Accuracy of the Panbio™ COVID-19/Flu A&B Rapid Panel: A Combination Antigen Rapid Diagnostic Test for the Omicron Variant and Influenza A Virus.
    Yamagishi H; Tamura D; Yamazaki M; Abe T; Mitamura K; Tajima T; Osaka H
    Viral Immunol; 2024 Aug; 37(6):317-321. PubMed ID: 39001845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of the Commercial Anti-SARS-CoV-2 Receptor Binding Domain Antibody Test with the Chemiluminescent Reduction Neutralizing Test and Possible Detection of Antibodies to Emerging Variants.
    Morinaga Y; Tani H; Terasaki Y; Nomura S; Kawasuji H; Shimada T; Igarashi E; Saga Y; Yoshida Y; Yasukochi R; Kaneda M; Murai Y; Ueno A; Miyajima Y; Fukui Y; Nagaoka K; Ono C; Matsuura Y; Fujimura T; Ishida Y; Oishi K; Yamamoto Y
    Microbiol Spectr; 2021 Dec; 9(3):e0056021. PubMed ID: 34851163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Sensitivity of Rapid Antigen Tests for the Delta Variant (B.1.617.2) of SARS-CoV-2.
    Sakai-Tagawa Y; Yamayoshi S; Halfmann PJ; Kawaoka Y
    Viruses; 2021 Oct; 13(11):. PubMed ID: 34834991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical assessment of the Roche SARS-CoV-2 rapid antigen test.
    Salvagno GL; Gianfilippi G; Bragantini D; Henry BM; Lippi G
    Diagnosis (Berl); 2021 Aug; 8(3):322-326. PubMed ID: 33554511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Panbio COVID-19 Rapid Antigen Detection Test Device for the Screening of Patients with COVID-19.
    Fenollar F; Bouam A; Ballouche M; Fuster L; Prudent E; Colson P; Tissot-Dupont H; Million M; Drancourt M; Raoult D; Fournier PE
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139420
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of the Panbio COVID-19 Antigen Rapid Diagnostic Test in Subjects Infected with Omicron Using Different Specimens.
    Galliez RM; Bomfim L; Mariani D; Leitão IC; Castiñeiras ACP; Gonçalves CCA; Ortiz da Silva B; Cardoso PH; Arruda MB; Alvarez P; Brindeiro R; Ota VA; Rodrigues DGM; da Costa LJ; Ferreira ODC; Castiñeiras TMPP; Faffe DS; Tanuri A
    Microbiol Spectr; 2022 Jun; 10(3):e0125022. PubMed ID: 35652635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Field evaluation of COVID-19 antigen tests versus RNA based detection: Potential lower sensitivity compensated by immediate results, technical simplicity, and low cost.
    Matsuda EM; de Campos IB; de Oliveira IP; Colpas DR; Carmo AMDS; Brígido LFM
    J Med Virol; 2021 Jul; 93(7):4405-4410. PubMed ID: 33788270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and Effectiveness Assessment of SARS-CoV-2 Antigenic Tests in Mass Screening of a Pediatric Population and Correlation with the Kinetics of Viral Loads.
    Lanari M; Biserni GB; Pavoni M; Borgatti EC; Leone M; Corsini I; Lazzarotto T
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-life evaluation of a COVID-19 rapid antigen detection test in hospitalized children.
    Eleftheriou I; Dasoula F; Dimopoulou D; Lebessi E; Serafi E; Spyridis N; Tsolia M
    J Med Virol; 2021 Oct; 93(10):6040-6044. PubMed ID: 34156112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection.
    Jääskeläinen AE; Ahava MJ; Jokela P; Szirovicza L; Pohjala S; Vapalahti O; Lappalainen M; Hepojoki J; Kurkela S
    J Clin Virol; 2021 Apr; 137():104785. PubMed ID: 33711694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Value of Rapid Antigen Tests for Identifying Carriers of Viable SARS-CoV-2.
    Shidlovskaya EV; Kuznetsova NA; Divisenko EV; Nikiforova MA; Siniavin AE; Ogarkova DA; Shagaev AV; Semashko MA; Tkachuk AP; Burgasova OA; Gushchin VA
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.